Institute for Molecular Cell Biology, Center for Molecular Biomedicine, Friedrich Schiller University of Jena, 07745 Jena, Germany.
J Biol Chem. 2010 Apr 2;285(14):10638-52. doi: 10.1074/jbc.M110.108688. Epub 2010 Feb 3.
AMP-activated protein kinase (AMPK) is a sensor of cellular energy state and a regulator of cellular homeostasis. In endothelial cells, AMPK is stimulated via the upstream kinases LKB1 and Ca(2+)/calmodulin-dependent protein kinase kinase beta (CaMKKbeta). Previously, AMPK has been reported to activate endothelial nitric-oxide synthase (eNOS). Using genetic and pharmacological approaches, we show that vascular endothelial growth factor (VEGF) stimulates AMPK in human and mice endothelial cells via CaMKKbeta. VEGF-induced AMPK activation is potentiated under conditions of energy deprivation induced by 2-deoxyglucose. To investigate the role of AMPK in endothelial function, CaMKKbeta, AMPKalpha1, or AMPKalpha2 was down-regulated by RNA interference, and studies in AMPKalpha1(-/-) mice were performed. We demonstrate that AMPK does not mediate eNOS phosphorylation at serine residue 1177 or 633, NO- dependent cGMP generation, or Akt phosphorylation in response to VEGF. Using inhibitors of eNOS or soluble guanylyl cyclase and small interfering RNA against eNOS, we show that NO does not act upstream of AMPK. Taken together, these data indicate that VEGF-stimulated AMPK and eNOS pathways act independently of each other. However, acetyl-CoA carboxylase, a key enzyme in the regulation of fatty acid oxidation, was phosphorylated in response to VEGF in an AMPKalpha1- and AMPKalpha2-dependent manner. Our results show that AMPKalpha1 plays an essential role in VEGF-induced angiogenesis in vitro (tube formation and sprouting from spheroids) and in vivo (Matrigel plug assay). In contrast, AMPKalpha2 was not involved in VEGF-triggered sprouting. The data suggest that AMPKalpha1 promotes VEGF-induced angiogenesis independently of eNOS, possibly by providing energy via inhibition of acetyl-CoA carboxylase.
AMP 激活的蛋白激酶 (AMPK) 是细胞能量状态的传感器和细胞内稳态的调节剂。在内皮细胞中,AMPK 通过上游激酶 LKB1 和 Ca(2+)/钙调蛋白依赖性蛋白激酶激酶β (CaMKKβ) 被激活。先前的研究表明,AMPK 可激活内皮型一氧化氮合酶 (eNOS)。我们使用遗传和药理学方法表明,血管内皮生长因子 (VEGF) 通过 CaMKKβ 在人和小鼠内皮细胞中刺激 AMPK。在 2-脱氧葡萄糖诱导的能量剥夺条件下,VEGF 诱导的 AMPK 激活得到增强。为了研究 AMPK 在血管内皮功能中的作用,通过 RNA 干扰下调 CaMKKβ、AMPKα1 或 AMPKα2,并在 AMPKα1(-/-) 小鼠中进行了研究。我们证明 AMPK 不介导 VEGF 诱导的 eNOS 丝氨酸残基 1177 或 633 的磷酸化、NO 依赖的 cGMP 生成或 Akt 的磷酸化。使用 eNOS 抑制剂或可溶性鸟苷酸环化酶和 eNOS 的小干扰 RNA,我们表明 NO 不作用于 AMPK 的上游。总之,这些数据表明 VEGF 刺激的 AMPK 和 eNOS 途径彼此独立地发挥作用。然而,乙酰辅酶 A 羧化酶,脂肪酸氧化调节的关键酶,以 AMPKα1 和 AMPKα2 依赖的方式对 VEGF 做出反应而被磷酸化。我们的结果表明,AMPKα1 在体外(管形成和球体发芽)和体内(Matrigel plugs 实验)VEGF 诱导的血管生成中发挥重要作用。相比之下,AMPKα2 不参与 VEGF 触发的发芽。数据表明,AMPKα1 通过抑制乙酰辅酶 A 羧化酶提供能量,可能独立于 eNOS 促进 VEGF 诱导的血管生成。